null Skip to main content

✨ Buy more, save 5% Ends

The LDN Book: How a Little-Known Generic Drug — Low Dose Naltrexone — Could Revolutionize Treatment for Autoimmune Diseases, Cancer, Autism, Depression, and More

The LDN Book: How a Little-Known Generic Drug — Low Dose Naltrexone — Could Revolutionize Treatment for Autoimmune Diseases, Cancer, Autism, Depression, and More

£26.86
New condition
(No reviews yet) Write a Review
Physical book delivery

Shipping calculated at checkout.

Estimated delivery
Adding to cart… The item has been added
Product Details
Author:
Linda Elsegood
Publisher:
Chelsea Green Publishing Co
Publication Date:
Feb 01, 2016
Binding:
Paperback / softback
ISBN-13:
9781603586641
ISBN10:
1603586644

Overview

Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more?“[LDN] raises hopes of reversing memory loss in old age.”—the GuardianOver 30,000 copies sold!Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? The LDN Book explains:The drug’s originsIts primary mechanismThe latest research from practicing physicians and pharmacists Compiled by Linda Elsegood of The LDN Research Trust—the world’s largest LDN charity organization with over 19,000 members worldwide—the book features ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices. The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.

Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more?

[LDN] raises hopes of reversing memory loss in old age.”—the Guardian

Over 30,000 copies sold!

Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects.

So why has it languished in relative medical obscurity?

The LDN Book explains:

  • The drug’s origins
  • Its primary mechanism
  • The latest research from practicing physicians and pharmacists

 

Compiled by Linda Elsegood of The LDN Research Trust—the world’s largest LDN charity organization with over 19,000 members worldwide—the book features ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices. 

The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.




  • | Author: Linda Elsegood
  • | Publisher: Chelsea Green Publishing Co
  • | Publication Date: Feb 01, 2016
  • | Number of Pages:
  • | Language:
  • | Binding: Paperback / softback
  • | ISBN-13: 9781603586641
  • | ISBN-10: 1603586644

Reviews

0 Reviews

Write a Review

No reviews yet.

Share your experience and help another reader choose their next book.

Advertisement — clicking an ad will take you to the advertiser’s website.

Discover your next great book

Get new releases, reader favourites, and special offers delivered to your inbox.